United States · FDA National Drug Code directory
EKTERLY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82928-300_16d31d7e-dc21-4cdb-92b8-56919827a192
- Product NDC
- 82928-300
- Form
- TABLET
- Composition / generic term
- sebetralstat
- Labeler
- KalVista Pharmaceuticals Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250703
- Source listing expiry
- 20271231
Source-listed ingredients
- SEBETRALSTAT — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (82928-300-04) / 1 TABLET in 1 BLISTER PACK (82928-300-01) · 82928-300-04
- 2 BLISTER PACK in 1 CARTON (82928-300-05) / 2 TABLET in 1 BLISTER PACK (82928-300-02) · 82928-300-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →